Rangeley Capital »

An2 Therapeutics shares owned by Rangeley Capital

Quarter-by-quarter ownership of An2 Therapeutics (ANTX) shares owned by Rangeley Capital from 13F filings

Historical chart of Rangeley Capital investment in An2 Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including An2 Therapeutics held by Rangeley Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in An2 Therapeutics by Rangeley Capital

Quarter filed Position value Share count Share price at filing
2025-09-30 $83k 65k 1.27
2025-06-30 $69k 65k 1.06
2025-03-31 $68k 50k 1.36